Coronavirus Latest Updates

  • Printer Friendly Version
  • Decrease Text Size
  • Increase Text Size
  • PDF


Sunday, October 20, 2019

WMCHealth Cardiology Director Publishes Study on New Treatment Benchmark

Posted By: Advancing Care

As seen in the November/December 2019 Issue of Advancing Care

A study published by Westchester Medical Center Health Network (WMCHealth) Director of Cardiology Julio Panza, MD, in the New England Journal of Medicine, concluded that a common test currently used to assess whether patients should undergo bypass surgery is unreliable as the sole basis for making an informed decision.

Assessing the results of a 20-year investigative effort, Dr. Panza and his team contend that the Myocardial Viability Test should be only part of a comprehensive and personalized assessment of each patient’s situation and that patients with ischemic cardiomyopathy should base their decision to opt for the procedure on the extent of their coronary disease.

“We hope the findings of this study will be utilized to better understand the complexity of the clinical problem in this high-risk population of patients and help define the patients’ needs for cardiac bypass surgery,” said Dr. Panza.

Visit us at Westchester Medical Center, a member of Westchester Medical Center Health Network, to learn more. Advancing Care. Here.

Pictured above: The study by Julio Panza, MD, Director of Cardiology at Westchester Medical Center, and his team reviewed data from a 20-year period.